Dr. Ayodele O. Ogunremi, MD

Dr. Ogunremi practices at Black Hills Dialysis in Rapid City, South Dakota.

Dr. Ogunremi's NPI, 1205884137, was assigned on May 4, 2006. Dr. Ogunremi holds South Dakota license 4955.

Dr. Ogunremi's primary practice is Black Hills Dialysis, at 640 Flormann St, Rapid City, SD 57701 in Pennington County. The practice phone is (605) 867-5983.

Dr. Ogunremi's primary practice is Black Hills Dialysis in Rapid City, South Dakota. Dr. Ogunremi is also affiliated with Monument Health Rapid City Hospital. The medical group on file is Monument Health Rapid City Hospital. Dmand AI also links Dr. Ogunremi to 3 more hospitals, 2 dialysis centers, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ogunremi practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Ogunremi's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Ogunremi is licensed in South Dakota.

CMS data shows 746 Medicare services from Dr. Ogunremi across 8 procedure codes in 2024, for 164 Medicare patients. Medicare paid $114,561 for them.

CMS counts 164 Medicare patients who saw Dr. Ogunremi in 2024. The largest group is 75 to 84, with 54 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 4.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ogunremi's median patient age at 73, with 49% women.

In 2024, Dr. Ogunremi wrote 1,471 Medicare Part D claims for 137 patients. 89% of them were for generic drugs. CMS names the drug for 1,334 of them, across 30 drugs with 11 or more claims each, at $134,477 in total drug cost. In 2023, CMS named 977 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Ogunremi for performance year 2024, reported through an alternative payment model (APM). Dr. Ogunremi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 14 general payments to Dr. Ogunremi from 6 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 69% of the total. Amgen Inc. paid the most, $125.